Canopy Growth (CGC) Other Non-Current Liabilities (2017 - 2025)
Canopy Growth's (CGC) quarterly Other Non-Current Liabilities came in at $17.7 million in Q4 2025, down 88.41% year-on-year from $153.0 million in Q4 2024, and down 7.49% quarter-over-quarter from $19.2 million in Q3 2025.
Canopy Growth (CGC) Other Non-Current Liabilities (2017 - 2025) Analysis & Trends
Canopy Growth has disclosed Other Non-Current Liabilities across 9 years of filings, most recently posting $17.7 million for Q4 2025.
- Other Non-Current Liabilities for Q4 2025 came in at $17.7 million, down 88.41% year-over-year; the trailing twelve-month figure through Dec 2025 was $17.7 million (down 88.41% YoY), and the FY2025 annual result was $25.3 million, down 52.57% from the prior year.
- Other Non-Current Liabilities came in at $17.7 million for Q4 2025 at Canopy Growth, down from $19.2 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $155.2 million in Q4 2021 to a low of $17.7 million in Q4 2025.
- The 5-year median for Other Non-Current Liabilities is $53.5 million (2023), against an average of $64.1 million.
- Across the five-year window, Other Non-Current Liabilities surged 251.69% in 2023 and slumped 88.41% in 2025, its largest moves.
- Canopy Growth's Other Non-Current Liabilities stood at $155.2 million in 2021, then plunged by 81.06% to $29.4 million in 2022, then surged by 82.45% to $53.6 million in 2023, then soared by 185.33% to $153.0 million in 2024, then plunged by 88.41% to $17.7 million in 2025.
- The last three Other Non-Current Liabilities figures came in at $17.7 million (Q4 2025), $19.2 million (Q3 2025), and $20.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.74 Mn |
| Sep 30, 2025 | 19.17 Mn |
| Jun 30, 2025 | 20.23 Mn |
| Mar 31, 2025 | 25.28 Mn |
| Dec 31, 2024 | 153.01 Mn |
| Sep 30, 2024 | 18.67 Mn |
| Jun 30, 2024 | 20.63 Mn |
| Mar 31, 2024 | 53.29 Mn |
| Dec 31, 2023 | 53.62 Mn |
| Sep 30, 2023 | 66.63 Mn |
| Jun 30, 2023 | 73.36 Mn |
| Mar 31, 2023 | 29.51 Mn |
| Dec 31, 2022 | 29.39 Mn |
| Sep 30, 2022 | 117.51 Mn |
| Jun 30, 2022 | 20.86 Mn |
| Mar 31, 2022 | 150.04 Mn |
| Dec 31, 2021 | 155.19 Mn |
| Sep 30, 2021 | 84.06 Mn |
| Jun 30, 2021 | 88.71 Mn |
| Mar 31, 2021 | 84.73 Mn |